🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Status
Completed
Location
Istituto Giannina Gaslini
Start Date
2006-05-31
Trial ID
NCT00323960
Treatments Being Tested
Early reduction of immunosuppressive agents after HLA matched donor transpl...
Status
Unknown
Location
Shanghai First People's HOSPITAL
Start Date
2010-01-01
Trial ID
NCT03150134
Treatments Being Tested
This study will evaluate whether conversion from cyclosporine, a calcineuri...
Status
Terminated
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00452361
Viral infections can profoundly influence alloimmune responses and hamper a...
Status
Completed
Location
Hospital Clinic Barcelona, University of Barcelona
Start Date
2008-04
Trial ID
NCT00668369
Treatments Being Tested
To assess the efficacy and safety of Abatacept as an immunosuppressive trea...
Status
Completed
Location
UZLeuven
Start Date
2019-04-01
Trial ID
NCT03871361
Treatments Being Tested
RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-10-24
Trial ID
NCT00045305
Observe the changes of tear volume in dry eye patients after Restasis treat...
Status
Completed
Location
Bascom Palmer Eye Institute
Start Date
2011-08
Trial ID
NCT00706940
Open label study to determine tolerability and efficacy of letermovir for C...
Status
Recruiting
Location
Penn Medicine at the University of Pennsylvania
Start Date
2024-04-04
Trial ID
NCT06066957
Treatments Being Tested
This randomized phase III trial studies how well graft-vs-host disease (GVH...
Status
Completed
Location
University of Colorado
Start Date
2010-11
Trial ID
NCT01231412
This study was designed to assess the safety, overall tolerability, and ant...
Status
Terminated
Location
Children's Hospital of Los Angeles
Start Date
2017-12-22
Trial ID
NCT03339401
Treatments Being Tested